Search
for
Sort by
Research 751–780 of 1000+
- Stem Cells in Regenerative Medicine: A Journey from Adult Stem Cells to Induced Pluripotent Cells
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
- A Kaleidoscope of Keratin Gene Expression and the Mosaic of Its Regulatory Mechanisms
- STAT3 Partly Inhibits Cell Proliferation via Direct Negative Regulation of FST Gene Expression
- Radiologie Aspects of Thallium Poisoning
- Progress of ursolic acid on the regulation of macrophage: summary and prospect
- Machine learning for nanozyme development in anti‐inflammatory applications
- Essential Oils and Melatonin as Functional Ingredients in Dogs
- Forsythiasides: A review of the pharmacological effects
- ERK1/2 Pathway Is Involved in the Enhancement of Fatty Acids from Phaeodactylum tricornutum Extract (PTE) on Hair Follicle Cell Proliferation
- The distribution of Preputial vessels in different severity of rat congenital hypospadias model: imaging study using micro-computerized tomography
- Clinical Presentation and Diagnosis of Multisystemic Eosinophilic Epitheliotropic Disease in a Miniature Donkey: A Case Report
- Bioconversion, Pharmacokinetics, and Therapeutic Mechanisms of Ginsenoside Compound K and Its Analogues for Treating Metabolic Diseases
- Effects of Platycladus orientalis Leaf Extract on the Growth Performance, Fur-Production, Serum Parameters, and Intestinal Microbiota of Raccoon Dogs
- Ox40-Cre–mediated deletion of BRD4 reveals an unexpected phenotype of hair follicle stem cells in alopecia
- Eclipta prostrata (L.) L.: Traditional Use, Phytochemistry, and Pharmacology
- Trends in the global organoid technology and industry: from organogenesis in a dish to the commercialization of organoids
- Viewpoint 7
- LHX2: a transcription factor in development, homeostasis, repair, and disease
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- The Influence of Monosaccharide Composition on the Bioactivity of Medicinal Plant Polysaccharides
- Innovations in skin microphysiological systems for nonclinical testing and FDA modernization
- Caffeine as an Active Molecule in Cosmetic Products for Hair Loss: Its Mechanisms of Action in the Context of Hair Physiology and Pathology
- Organoids in skin wound healing
- The Progress in Bioprinting and Its Potential Impact on Health-Related Quality of Life
- Testosterone: The Male Sex Hormone
- Hair-bearing human skin generated entirely from pluripotent stem cells
- Human Eccrine Sweat Gland Cells Can Reconstitute a Stratified Epidermis
- Multicolor Cell Barcoding Technology for Long-Term Surveillance of Epithelial Regeneration in Zebrafish